Please login to the form below

Not currently logged in
Email:
Password:

Access to Medicines Index

This page shows the latest Access to Medicines Index news and features for those working in and with pharma, biotech and healthcare.

GSK tops Access to Medicines Index for fifth time running

GSK tops Access to Medicines Index for fifth time running

The company topped the Access to Medicines Index for the fifth consecutive time after the biannual good practice report found it “the most access-oriented company” of the top 20 pharma ... The Access to Medicines Index 2016. View the Access to

Latest news

  • GSK unveils access plan for low-income countries GSK unveils access plan for low-income countries

    The company's chief executive Sir Andrew Witty - who will step down next year - announced the measure just ahead of the UN High Level Panel on Access to Medicines yesterday. ... GSK already has a good track record on medicines access, ranking at number

  • Novartis to make 15 drugs available at $1 a month Novartis to make 15 drugs available at $1 a month

    Novartis has launched an access programme aimed at low-and middle-income countries that will make 15 of its medicines for chronic diseases available at a knockdown price. ... Novartis was ranked fourth in the 2014 Access to Medicines Index funded by the

  • GSK tops pharma access to medicines table GSK tops pharma access to medicines table

    The biannual Access To Medicines Index (ATMI) - which is funded by the Bill &Melinda Gates Foundation and the UK and Dutch governments - puts GlaxoSmithKline at the top of its rankings in ... The Access to Medicines Index 2014. "In recent years,

  • EU pharma heading efforts to get drugs to the poor

    The Access to Medicines Index was launched on June 16 and shows that only one US manufacturer, Merck &Co, which came third, has made it into the top seven. ... Leereveld said that the most striking fact is that the index, set up by the Access to Medicine

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

Switzerland
Switzerland: a life sciences hub
Switzerland has a rich diversity of pharma and biotech companies that sustain activity and help maintain its reputation as a highly innovative country...
Responding to dynamic shifts in value communications
OPEN Health’s Beth Lesher and Annemarie Clegg examine what the convergence of medical communications and market access means for pharmaceutical companies....
Doing what we can and having fun doing it: our fundraising month
Charities are facing a number of challenges just to stay afloat amidst the current COVID-19 pandemic. Fundraisers are being cancelled and public donations are not as abundant as they have...

Infographics